Cargando…

Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors

INTRODUCTION: Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in intensive care units (ICUs) during the ongoing coronavirus disease 2019 (COVID-19) pandemic. The unfavorable resistance profile of C. auris and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Briano, Federica, Magnasco, Laura, Sepulcri, Chiara, Dettori, Silvia, Dentone, Chiara, Mikulska, Malgorzata, Ball, Lorenzo, Vena, Antonio, Robba, Chiara, Patroniti, Nicolò, Brunetti, Iole, Gratarola, Angelo, D’Angelo, Raffaele, Di Pilato, Vincenzo, Coppo, Erika, Marchese, Anna, Pelosi, Paolo, Giacobbe, Daniele Roberto, Bassetti, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995918/
https://www.ncbi.nlm.nih.gov/pubmed/35404010
http://dx.doi.org/10.1007/s40121-022-00625-9
_version_ 1784684387812507648
author Briano, Federica
Magnasco, Laura
Sepulcri, Chiara
Dettori, Silvia
Dentone, Chiara
Mikulska, Malgorzata
Ball, Lorenzo
Vena, Antonio
Robba, Chiara
Patroniti, Nicolò
Brunetti, Iole
Gratarola, Angelo
D’Angelo, Raffaele
Di Pilato, Vincenzo
Coppo, Erika
Marchese, Anna
Pelosi, Paolo
Giacobbe, Daniele Roberto
Bassetti, Matteo
author_facet Briano, Federica
Magnasco, Laura
Sepulcri, Chiara
Dettori, Silvia
Dentone, Chiara
Mikulska, Malgorzata
Ball, Lorenzo
Vena, Antonio
Robba, Chiara
Patroniti, Nicolò
Brunetti, Iole
Gratarola, Angelo
D’Angelo, Raffaele
Di Pilato, Vincenzo
Coppo, Erika
Marchese, Anna
Pelosi, Paolo
Giacobbe, Daniele Roberto
Bassetti, Matteo
author_sort Briano, Federica
collection PubMed
description INTRODUCTION: Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in intensive care units (ICUs) during the ongoing coronavirus disease 2019 (COVID-19) pandemic. The unfavorable resistance profile of C. auris and the potential high mortality of C. auris infections represent an important challenge for physicians. METHODS: We conducted a single-center retrospective study including all patients admitted to ICUs with isolation of C. auris in any non-sterile body site between February 20, 2020, and May 31, 2021. The primary aim of the study was to assess the cumulative incidence of C. auris candidemia in colonized patients. The secondary aim was to identify predictors of C. auris candidemia in the study population. RESULTS: During the study period, 157 patients admitted to ICUs in our hospital became colonized with C. auris; 59% of them were affected by COVID-19. Overall, 27 patients (17%) developed C. auris candidemia. The cumulative risk of developing C. auris candidemia was > 25% at 60 days after first detection of C. auris colonization. Seven patients with C. auris candidemia (26%) also developed a late recurrent episode. All C. auris blood isolates during the first occurring episode were resistant to fluconazole and susceptible to echinocandins, while 15 (56%) were resistant to amphotericin B. During late recurrent episodes, emergent resistance to caspofungin and amphotericin B occurred in one case each. In the final multivariable model, only multisite colonization retained an independent association with the development of C. auris candidemia. CONCLUSION: Candida auris candidemia may occur in up to one fourth of colonized critically ill patients, and multisite colonization is an independent risk factor for the development of candidemia. Implementing adequate infection control measures remains crucial to prevent colonization with C. auris and indirectly the subsequent development of infection.
format Online
Article
Text
id pubmed-8995918
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-89959182022-04-11 Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors Briano, Federica Magnasco, Laura Sepulcri, Chiara Dettori, Silvia Dentone, Chiara Mikulska, Malgorzata Ball, Lorenzo Vena, Antonio Robba, Chiara Patroniti, Nicolò Brunetti, Iole Gratarola, Angelo D’Angelo, Raffaele Di Pilato, Vincenzo Coppo, Erika Marchese, Anna Pelosi, Paolo Giacobbe, Daniele Roberto Bassetti, Matteo Infect Dis Ther Original Research INTRODUCTION: Candida auris (C. auris) is an emerging nosocomial pathogen, and a sharp rise in cases of colonization and infection has been registered in intensive care units (ICUs) during the ongoing coronavirus disease 2019 (COVID-19) pandemic. The unfavorable resistance profile of C. auris and the potential high mortality of C. auris infections represent an important challenge for physicians. METHODS: We conducted a single-center retrospective study including all patients admitted to ICUs with isolation of C. auris in any non-sterile body site between February 20, 2020, and May 31, 2021. The primary aim of the study was to assess the cumulative incidence of C. auris candidemia in colonized patients. The secondary aim was to identify predictors of C. auris candidemia in the study population. RESULTS: During the study period, 157 patients admitted to ICUs in our hospital became colonized with C. auris; 59% of them were affected by COVID-19. Overall, 27 patients (17%) developed C. auris candidemia. The cumulative risk of developing C. auris candidemia was > 25% at 60 days after first detection of C. auris colonization. Seven patients with C. auris candidemia (26%) also developed a late recurrent episode. All C. auris blood isolates during the first occurring episode were resistant to fluconazole and susceptible to echinocandins, while 15 (56%) were resistant to amphotericin B. During late recurrent episodes, emergent resistance to caspofungin and amphotericin B occurred in one case each. In the final multivariable model, only multisite colonization retained an independent association with the development of C. auris candidemia. CONCLUSION: Candida auris candidemia may occur in up to one fourth of colonized critically ill patients, and multisite colonization is an independent risk factor for the development of candidemia. Implementing adequate infection control measures remains crucial to prevent colonization with C. auris and indirectly the subsequent development of infection. Springer Healthcare 2022-04-11 2022-06 /pmc/articles/PMC8995918/ /pubmed/35404010 http://dx.doi.org/10.1007/s40121-022-00625-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Briano, Federica
Magnasco, Laura
Sepulcri, Chiara
Dettori, Silvia
Dentone, Chiara
Mikulska, Malgorzata
Ball, Lorenzo
Vena, Antonio
Robba, Chiara
Patroniti, Nicolò
Brunetti, Iole
Gratarola, Angelo
D’Angelo, Raffaele
Di Pilato, Vincenzo
Coppo, Erika
Marchese, Anna
Pelosi, Paolo
Giacobbe, Daniele Roberto
Bassetti, Matteo
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
title Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
title_full Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
title_fullStr Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
title_full_unstemmed Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
title_short Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors
title_sort candida auris candidemia in critically ill, colonized patients: cumulative incidence and risk factors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8995918/
https://www.ncbi.nlm.nih.gov/pubmed/35404010
http://dx.doi.org/10.1007/s40121-022-00625-9
work_keys_str_mv AT brianofederica candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT magnascolaura candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT sepulcrichiara candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT dettorisilvia candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT dentonechiara candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT mikulskamalgorzata candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT balllorenzo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT venaantonio candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT robbachiara candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT patronitinicolo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT brunettiiole candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT gratarolaangelo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT dangeloraffaele candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT dipilatovincenzo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT coppoerika candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT marcheseanna candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT pelosipaolo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT giacobbedanieleroberto candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors
AT bassettimatteo candidaauriscandidemiaincriticallyillcolonizedpatientscumulativeincidenceandriskfactors